Genevieve Allou, APRN
Nurse Practitioner · Omaha, NENPI 1942836960
Payments from drug & device makers
Across 569 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Gilead$2K
- Johnson & Johnson$922
- Takeda Pharmaceuticals U.S.A., Inc.$752
- Sanofi$653
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 120 | $2,714 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 96 | $1,744 |
| Gilead | 66 | $1,600 |
| Johnson & Johnson | 70 | $922 |
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $752 |
| Sanofi | 24 | $653 |
| Ardelyx, Inc. | 17 | $508 |
| Intercept Pharmaceuticals, Inc. | 16 | $433 |
| Madrigal Pharmaceuticals | 13 | $345 |
| Regeneron Healthcare Solutions, Inc. | 14 | $268 |
| Ferring Pharmaceuticals Inc. | 9 | $255 |
| Aimmune Therapeutics, Inc. | 3 | $238 |
| Ironwood Pharmaceuticals, Inc | 17 | $233 |
| Bristol Myers Squibb | 18 | $228 |
| Ipsen Biopharmaceuticals, Inc | 2 | $148 |
| Janssen Scientific Affairs, LLC | 1 | $109 |
| Lilly USA, LLC | 3 | $77 |
| Pfizer | 5 | $74 |
| Celltrion USA Inc. | 4 | $70 |
| AstraZeneca | 3 | $47 |
| Organon | 3 | $43 |
| Novo Nordisk | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Merck | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| Boston Scientific | 1 | $24 |
| Boehringer Ingelheim | 1 | $21 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Sandoz | 1 | $17 |
| Exact Sciences | 1 | $17 |
| QOL Medical, LLC | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Amgen | 1 | $14 |
How this compares
$11,777 in reported general payments places this provider in the 95th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Omaha
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Kari CunninghamOmaha$53K
- Laura DonovanOmaha$49K
- Kathleen HealeyOmaha$36K
- Katie RuchOmaha$26K
- Amanda GuggenmosOmaha$23K
- Amy YagerOmaha$15K
- Cara SchiesslerOmaha$14K
- Lindsay OneilOmaha$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.